Ardian, a world leading private investment house, has announced that it has acquired a 50-percent ownership stake in ANGUS Chemical Company from Golden Gate Capital. Golden Gate Capital, which initially acquired ANGUS in February 2015 from The Dow Chemical Company, will retain a 50-percent stake in ANGUS. Additional terms of the transaction were not disclosed.
Latham & Watkins LLP represents Ardian in the transaction with a corporate deal team led by New York partner David Kurzweil and Paris/London partner Gaëtan Gianasso, with New York associates Leah Sauter, Adam Rosenthal and Daniel Goldschmidt. Advice was also provide on tax matters by New York partner Lisa Watts; on employee benefits and compensation matters by Washington, D.C. partner Adam Kestenbaum; and on antitrust matters by Paris partner Adrien Giraud.